C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2002
11/07/2002	CA2444499A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	CA2439943A1 Benzimidazoles that are useful in treating sexual dysfunction
11/06/2002	EP1254904A1 Novel piperidine compounds and drugs containing the same
11/06/2002	EP1254903A1 4-Amino-2-(pyridin-2-yl)pyrimidine as microbicidal active substances
11/06/2002	EP1254901A1 Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient
11/06/2002	EP1254899A2 Piperazine derivatives and their use as anti-inflammatory agents
11/06/2002	EP1254898A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
11/06/2002	EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
11/06/2002	EP1254138A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
11/06/2002	EP1254136A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
11/06/2002	EP1254133A2 Indol-3-yl derivatives
11/06/2002	EP1254119A1 Pyrimidine derivatives as selective inhibitors of cox-2
11/06/2002	EP1254116A1 Alpha v integrin receptor antagonists
11/06/2002	EP1254115A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
11/06/2002	EP1254114A2 Melanocortin receptor agonists and antagonists
11/06/2002	EP1254113A1 N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv
11/06/2002	EP1253925A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
11/06/2002	EP1253916A1 Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists
11/06/2002	EP1031570B1 Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, method for producing the same and pharmaceutical preparation for treating mycobacterioses as well as lung chronic and non specific conditions, sexually transmitted diseases and the resulting immuno-deficiency
11/06/2002	EP1030843A4 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
11/06/2002	EP0993459B1 Compounds useful for inhibition of farnesyl protein transferase
11/06/2002	EP0915853B1 Substituted 3-phenyl pyrazoles
11/06/2002	EP0912559B1 Fused heterocyclic compounds as protein tyrosine kinase inhibitors
11/06/2002	EP0901488B1 2,4-diaminopyrimidine derivatives
11/06/2002	EP0901373B1 Alpha v Beta 3 ANTAGONISTS
11/06/2002	EP0711300B1 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
11/06/2002	CN1378545A Substituted pyrroles as antiproliferative agents for treatment of cancer
11/06/2002	CN1378544A Substituted azoles compounds
11/06/2002	CN1378543A Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
11/06/2002	CN1378542A FAB I inhibitors
11/06/2002	CN1378540A New piperazine and piperidine compounds
11/06/2002	CN1378537A 嘧啶衍生物 Pyrimidine derivatives
11/06/2002	CN1378534A Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of coagulation cascade
11/06/2002	CN1378533A Phenoxypropylamine compounds
11/06/2002	CN1377880A Compound for curing vascular complication, its preparing method and treating use
11/06/2002	CN1377647A 4-mercaptopyrrolidinyl derivative as fernesyl transferase inhibitor
11/06/2002	CN1093858C Quinoline and quinozoline compounds useful in therapy, particularly in the treatment of begnin prostatic hyperplasia
11/06/2002	CN1093857C New piperazine and piperidine compounds
11/06/2002	CN1093856C Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds
11/06/2002	CN1093761C New pharmacological use of all-receptor antagonists
11/05/2002	US6476060 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
11/05/2002	US6476055 5,5-disubstituted thiazolidine derivative pesticides
11/05/2002	US6476054 Cyclic amine modulators of chemokine receptor activity
11/05/2002	US6476052 Isoindolines, method of use, and pharmaceutical compositions
11/05/2002	US6476051 For therapy of psychosis, acute mania, mild anxiety states, or depression in combination with psychotic episodes
11/05/2002	US6476050 3-substituted piperidines comprising urea functionality, and methods of use thereof
11/05/2002	US6476045 Indole and azaindole derivatives and their use as tachykinin antagonists, and in particular as neurokinin-1 receptor antagonist
11/05/2002	US6476041 1,4 substituted piperidinyl NMDA/NR2B antagonists
11/05/2002	US6476040 Processes and intermediates for preparing anti-cancer compounds
11/05/2002	US6476031 Quinazoline derivatives as medicaments
11/05/2002	US6476028 Compounds and methods
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
11/05/2002	US6476025 Phenylphennanthridines with PDE-IV inhibiting activity
11/05/2002	US6476023 Aromatic heterocyclic compounds as anti-inflammatory agents
11/05/2002	US6475509 Covalent conjugates of sodium channel blockers and active compounds
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002086078A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
10/31/2002	WO2002085925A2 Melanocortin receptor ligands
10/31/2002	WO2002085906A2 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	WO2002085899A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	WO2002085897A1 Heterocyclic compounds for aging-related and diabetic vascular complications
10/31/2002	WO2002085894A1 Arylindenopyridines with pde inhibiting activity
10/31/2002	WO2002085892A1 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/31/2002	WO2002085890A1 Benzimidazolone derivatives
10/31/2002	WO2002085889A1 Crystalline form of omeprazole
10/31/2002	WO2002085888A1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
10/31/2002	WO2002085887A1 Phenyl- and pyridyl-piperidines with tnf activity
10/31/2002	WO2002085886A2 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
10/31/2002	WO2002085885A1 Piperazino-derivatives and their use as pde4 inhibitor
10/31/2002	WO2002085870A1 Novel azoles having an insecticidal action
10/31/2002	WO2002085866A1 Novel compounds
10/31/2002	WO2002085860A1 Pyrazole derivatives for treating hiv
10/31/2002	WO2002085859A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
10/31/2002	WO2002085857A2 Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
10/31/2002	WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002	WO2002085854A1 5-aryl-1.3.3.-trimethyl-2-methylene-indoline derivatives and salts thereof, methods for the production and use of said compounds for the temporary coloration of fibres
10/31/2002	WO2002085853A2 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/31/2002	WO2002085851A1 Pyrrole derivative
10/31/2002	WO2002085850A1 Cyclic amidine derivative
10/31/2002	WO2002085843A2 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/31/2002	WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002	WO2002085364A1 Farnesyl protein transferase inhibitors for treating cachexia
10/31/2002	WO2002085361A1 Benzimidazolone compounds
10/31/2002	WO2002085357A1 Nociceptin analogs
10/31/2002	WO2002085312A2 Process for purifying 6-methoxy omeprazole
10/31/2002	WO2002085291A2 Nociceptin analogs
10/31/2002	WO2002069895A3 Heterocyclic analgesic compounds and methods of use thereof
10/31/2002	WO2002048105A3 Aryloxy piperidinyl derivatives for the treatment of depression
10/31/2002	WO2002040474A3 Heterocyclylalkyl piperidine derivatives and their use as antimicrobial agents
10/31/2002	WO2002026720A3 PIPERAZINE BASED INHIBITORS OF FACTOR Xa
10/31/2002	WO2002022611A3 Caspase inhibitors and uses thereof
10/31/2002	US20020161240 Synthetic multimerizing agents
10/31/2002	US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002	US20020161234 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde
10/31/2002	US20020161224 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
10/31/2002	US20020161025 N-substituted indole-3glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action
10/31/2002	US20020161024 Administering 2-(piperidin-2,6-dion-3-yl),4-amino-isoindolin-1-one to treat an eye condition
10/31/2002	US20020161022 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/31/2002	US20020161010 Treatment of various disorders associated with enhanced activity of kinase p38-alpha and/or transforming growth factor beta; antiinflammatory agents
10/31/2002	US20020161008 Agonists, antagonists or inverse agonists for GABAA brain receptors; useful in diagnosis and treatment of anxiety, depression

1 ... 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 ... 1080